{{Rsnum
|rsid=16977195
|Gene=AGBL1
|Chromosome=15
|position=86441009
|Orientation=plus
|GMAF=0.0551
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=AGBL1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 91.0 | 9.0 | 0.0
| HCB | 67.6 | 31.6 | 0.7
| JPT | 83.8 | 16.2 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 67.6 | 31.6 | 0.7
| CHD | 73.4 | 25.7 | 0.9
| GIH | 87.1 | 12.9 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 98.3 | 1.7 | 0.0
| MKK | 98.7 | 1.3 | 0.0
| TSI | 93.1 | 6.9 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs16977195
|PubMedID=18347602
|Condition=Schizophrenia
|Gene=AGBL1
|Risk Allele=
|pValue=2.00E-006
|OR=6.01
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs16977195
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18347602; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genomewide association for schizophrenia in the CATIE study: results of stage 1 (Initial Sample Size: 738 cases, 733 controls; Replication Sample Size: NR). This variant is associated with Schizophrenia.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356462
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs16977195
|overall_frequency_n=1
|overall_frequency_d=128
|overall_frequency=0.0078125
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}